DSIP (Delta Sleep-Inducing Peptide) Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about DSIP (Delta Sleep-Inducing Peptide) dosing — protocols, safety, and where to buy.
Dose Range
100–300 mcg per injection
Frequency
Once daily, 30–60 minutes before bedtime
Cycle Length
10–14 days; can repeat after 1-week break
Half-Life
~7–8 minutes IV (short, but sleep-promoting effects last hours)
Administration Routes
Quick Reconstitution Calculator
Calculate syringe units instantly
Syringe Draw
10.0 units
2500 mcg/ml · 0.100 ml draw
Dosing Protocols
Beginner Protocol: DSIP Single-Agent Trial
This protocol is designed for users new to DSIP who want to trial it for sleep support. The goal is to establish whether you are a responder, identify a workable dose, and maintain realistic expectations.
Prerequisites
- Sleep hygiene basics optimized: Dark bedroom, cool temperature (65-68°F), consistent sleep/wake timing, no screens 1 hour before bed, limited caffeine after noon, limited alcohol especially within 4 hours of bed. Without these foundations, no sleep aid works well.
- Realistic expectations: DSIP produces mild, variable effects. It is not a benzodiazepine and will not produce dramatic sedation. If you need aggressive pharmacological sleep help, see a sleep medicine physician.
- Rule out underlying conditions: Consider evaluation for sleep apnea (especially if you snore, have morning headaches, or daytime sleepiness), RLS, untreated depression/anxiety, thyroid dysfunction. Don't mask an underlying disorder with peptides.
- Source quality: Obtain DSIP from a reputable research peptide supplier with batch testing. Counterfeit or degraded product is a major risk factor for non-response.
- Sterile injection practices: If injecting subcutaneously, learn proper technique (alcohol swab, fresh needle, proper site rotation, safe disposal).
Baseline Assessment (1-2 Weeks Before Starting)
Track for 1-2 weeks:
- Sleep latency (time to fall asleep)
- Total sleep time
- Subjective sleep quality (1-10)
- Morning alertness (1-10)
- Daytime energy (1-10)
- Any stress or anxiety markers
Consumer sleep tracking (Oura, Whoop, Apple Watch Sleep, Fitbit) provides useful objective context. Track a minimum of 7 consecutive nights to establish your baseline.
Starting Protocol
Option A: Subcutaneous Injection (Most Common)
- Preparation: Reconstitute 5 mg DSIP vial with 2 mL bacteriostatic water. This yields 2,500 mcg/mL; for a 200 mcg dose, draw 0.08 mL (8 units on an insulin syringe).
- Starting dose: 100 mcg SC 30-60 minutes before intended sleep time
- Dose: Week 1 — 100 mcg nightly; Week 2 — 150 mcg nightly; Week 3+ — 200 mcg nightly if tolerated
- Injection sites: Rotate between abdomen (avoiding 2-inch radius around navel), lateral thigh, upper outer buttock. Use 31g insulin syringe for comfort.
- Timing: Consistent timing is ideal; dose 30-60 minutes before your target bedtime
Option B: Intranasal Spray
- Preparation: Typical commercial nasal spray is 5 mg DSIP in 2-5 mL vehicle (concentration varies by supplier)
- Starting dose: 1 spray in each nostril (~200 mcg total typical) 30 minutes before bed
- Technique: Tilt head slightly forward, spray into nostril, gently inhale; avoid blowing nose immediately after
Response Assessment (Weeks 2-4)
Track the same sleep metrics as baseline. After 2 weeks at your target dose:
Good responder (30-40% of users):
- Sleep latency reduced by 10-20+ minutes
- Subjective sleep quality improved by 1-2 points
- Morning alertness improved
- Continue current protocol
Partial responder (30-40% of users):
- Some improvement but modest
- Consider dose optimization (25-50 mcg adjustment)
- Consider stacking with complementary sleep aids
- Continue 2-4 more weeks to assess
Non-responder (20-40% of users):
- No detectable sleep benefit after 4 weeks at therapeutic dose
- Not all users respond to DSIP; biology is variable
- Consider discontinuation and alternative approaches
Ongoing Use Patterns
If you're a responder, sustainable use patterns include:
Pattern A: Nightly Use with Periodic Breaks
- Nightly for 8-12 weeks
- Break of 2-4 weeks
- Resume as needed
- Rationale: Prevents theoretical tolerance, validates ongoing need
Pattern B: Intermittent Use
- 3-4 nights per week (e.g., before demanding workdays)
- Off nights rely on sleep hygiene alone
- Rationale: Reduces total drug exposure, distinguishes pharmacological from placebo effects
Pattern C: As-Needed Use
- For occasional disrupted sleep (travel, stress, etc.)
- Not as a daily aid
- Rationale: Minimal pharmacological dependence, reserve tool for when needed
When to Adjust or Discontinue
Increase dose if:
- Response is clear but suboptimal
- Move up in 50 mcg increments max
- Do not exceed 300 mcg without specific reason
Decrease dose if:
- Morning grogginess
- Vivid dreams disrupting sleep
- Any adverse effects
Discontinue if:
- No response after 4-6 weeks at therapeutic dose
- Intolerable side effects
- Changing health circumstances
- Exploring different approaches
What Realistic Success Looks Like
A successful DSIP protocol in a responder typically produces:
- Sleep latency improvement of 10-20 minutes
- Subjective sleep quality improvement of 1-2 points on 10-point scale
- Modest improvement in slow-wave sleep percentage (if measured)
- No morning grogginess or impairment
- No development of tolerance over 3-6 months
- Easy discontinuation without rebound insomnia when breaks are taken
This is genuinely useful for many users but it is NOT dramatic. If you're expecting to be knocked unconscious at therapeutic dose, DSIP will disappoint you. If you're looking for a mild, non-habit-forming sleep assist that supports baseline sleep hygiene rather than replacing it, DSIP can be a reasonable tool.
Common Mistakes
- Doses too high: More DSIP doesn't produce more sleep; it produces more next-day grogginess. Start low, titrate modestly.
- Dosing too close to bed: The 30-60 minute window matters; last-minute dosing may push effects past your sleep period.
- Ignoring sleep hygiene: No peptide compensates for inconsistent schedules or phone use in bed.
- Stacking too aggressively early: Isolate DSIP's effect first, then add complements. Starting with 5 sleep aids makes it impossible to know what's working.
- Unrealistic expectations: Benzodiazepine-level sedation is not the DSIP experience. Adjust expectations.
- Low-quality sources: Gray-market peptides vary enormously in quality. A reputable source matters more for DSIP than for many compounds because the effect is subtle to begin with.
Intermediate Protocol: DSIP with Comprehensive Sleep Optimization
For users who have completed a beginner DSIP trial and confirmed response, want to optimize outcomes, and pair DSIP with evidence-based sleep enhancement strategies.
Prerequisites
- Completed beginner protocol with documented response
- Sleep tracking data (consumer device or sleep diary) demonstrating baseline and DSIP-enhanced metrics
- Optimized sleep hygiene foundations
- Underlying sleep disorders ruled out or appropriately managed
- Understanding of the stacking rationale and drug interaction considerations
Protocol Components
Foundation: DSIP Core Dose
- DSIP 200-250 mcg SC 30-45 minutes before bed
- OR DSIP 250-400 mcg intranasal 30 minutes before bed
- Consistent nightly timing ideal
- Rotate between delivery routes only if you want to compare subjectively
Mineral Support
- Magnesium glycinate 400-600 mg 1-2 hours before bed
- Glycinate form for better absorption and less GI upset than oxide or citrate
- Divided dose if single dose causes loose stools
- Optional: Magnesium threonate 1,500-2,000 mg evening
- Alternative form with superior BBB penetration
- More expensive but may enhance sleep quality specifically
Amino Acids
- Glycine 3-5 g at bedtime
- Dissolved in water or taken as powder
- Produces mild core body temperature drop supporting sleep
- Evidence: Multiple small RCTs showing improved sleep quality
- L-theanine 200 mg 30-60 minutes before bed
- Promotes alpha waves and GABAergic tone
- Synergizes with magnesium and glycine
Herbal Support
- Apigenin 50 mg (from chamomile or isolated) 30 minutes before bed
- Partial benzodiazepine receptor agonist
- Mild anxiolytic and sleep-promoting
- Ashwagandha (KSM-66) 600 mg split morning/evening
- Adaptogen reducing evening cortisol
- Not sleep-promoting acutely but improves sleep over 4-6 weeks
Circadian Anchors
- Low-dose melatonin 0.3-0.5 mg 30 minutes before bed
- CRITICAL: use actual low dose, not the common 3-10 mg products
- Target is circadian signal, not sedation
- Higher doses cause vivid dreams, hangover, and reduced benefit over time
- Morning bright light exposure 10-15 minutes within first hour of waking
- Strongest circadian anchor available
- 10,000 lux light box if natural light unavailable
- Evening light hygiene
- No screens 1 hour before bed OR use blue-blocker glasses
- Dim home lighting after sunset
Sleep Environment Optimization
- Temperature: 65-68°F bedroom
- Darkness: Blackout curtains, no LEDs visible, sleep mask if needed
- Sound: White noise or ambient (not music with lyrics); earplugs if partner snores
- Bedding: Cool materials, quality mattress appropriate for body type
- No device charging in bedroom: Remove phone, tablet, laptop
Timing Protocol
- 3-4 hours before bed: Last meal (substantial), last caffeine (for most people this means before noon)
- 2 hours before bed: Last intense exercise; last alcohol
- 1-2 hours before bed: Magnesium, ashwagandha (evening dose)
- 1 hour before bed: Begin wind-down routine, blue-blocker glasses on, dim lights
- 60 minutes before bed: DSIP injection (if SC) or intranasal
- 30 minutes before bed: Glycine, L-theanine, apigenin, low-dose melatonin
- Bedtime: Consistent within 30-minute window nightly
Weekly Structure
Nightly (7 nights): Foundation components (magnesium, glycine, L-theanine, glycine, melatonin, apigenin)
DSIP 5 nights per week (typical "5 on, 2 off"):
- Use on nights when sleep is highest priority
- Take breaks on 1-2 nights weekly to distinguish pharmacological from placebo effect
- Consider taking breaks on less-demanding next-day schedules
Monitoring
- Weekly sleep tracking review (consumer device or diary)
- Monthly subjective assessment: quality, latency, total time, morning alertness
- Quarterly: Consider short (1-2 week) total break to reassess
Adjustment Strategies
If sleep quality plateaus:
- Consider adding CJC-1295/Ipamorelin 100/200 mcg SC at bedtime for GH-axis support
- Consider addressing evening cortisol more aggressively (ashwagandha dose increase, phosphatidylserine)
- Evaluate for emerging sleep apnea (weight changes, alcohol patterns)
If morning grogginess develops:
- Reduce DSIP by 50 mcg
- Consider dosing 15 minutes earlier
- Check stack total load — may be oversedating
If vivid dreams disrupt sleep:
- Reduce DSIP dose
- Reduce or eliminate melatonin (major contributor to vivid dreams at higher doses)
- Consider dosing earlier in evening
If stress is a major sleep driver:
- Add Selank 300 mcg intranasal 1-2x daily for daytime anxiolysis
- Consider daily meditation or breath work practice
- Address specific stressors systematically
Integration with Other Goals
If also on TRT or HPG support:
- Ensure appropriate estradiol management (imbalanced E2 disrupts sleep)
- Time testosterone injections away from bedtime if stimulating
- Enclomiphene or Gonadorelin don't disrupt sleep directly
If using GLP-1 agonists:
- GLP-1s can cause insomnia in some users especially during titration
- DSIP stack may help weather this transition
- Ensure GLP-1 injection not too close to bedtime
If using stimulating nootropics:
- Modafinil, Methylphenidate, racetams with cholinergic stimulants: dose early in day
- Don't attempt to "outrun" overstimulation with more sleep aids
- Let stimulants clear before sleep window
Sustainability Philosophy
The goal of the intermediate protocol is to enhance sleep quality through a broad foundation such that DSIP becomes an optional enhancement rather than a required fix. Over 6-12 months of consistent implementation, most users find they can maintain good sleep with just the foundation stack plus intermittent DSIP rather than nightly use. This is a sign of success — declining dependence on the pharmacological component as the foundation becomes robust.
Labs to Consider (Optional)
While DSIP itself doesn't require lab monitoring, comprehensive sleep optimization may benefit from:
- Ferritin (low iron causes RLS and disrupted sleep)
- Vitamin D (deficiency correlates with sleep disorders)
- Thyroid panel (hyper or hypo can disrupt sleep)
- HbA1c (dysglycemia disrupts sleep)
- Testosterone if male >40 (low T is a common overlooked cause of poor sleep)
- Cortisol curve if available (identifies dysregulated stress response)
Advanced Protocol: DSIP in Complex Sleep Disorders and Multimodal Peptide Stacks
This protocol is used by experienced biohackers addressing chronic sleep dysfunction alongside comprehensive health optimization. It integrates DSIP with other research peptides, addresses underlying physiology, and represents sophisticated stacking that requires careful tracking.
Prerequisites
- Thorough medical evaluation excluding treatable sleep disorders
- Completed intermediate protocol with documented response patterns
- Experience with multiple peptide injections
- Reliable access to high-quality research peptide sources
- Willingness to track comprehensively (sleep data, subjective measures, labs)
- Physician awareness of the approach, ideally with input
Core Components
DSIP as Part of Evening Peptide Stack
Evening peptide injection (before bed):
- DSIP 200-300 mcg SC 60 minutes before bed
- CJC-1295 100 mcg SC at bedtime (combined with Ipamorelin in single syringe)
- Ipamorelin 200 mcg SC at bedtime
- Rationale: GH/IGF-1 pulse during deep sleep enhances recovery; DSIP supports the sleep architecture that makes this pulse possible
OR evening single-peptide approach:
- Tesamorelin 1 mg SC at bedtime (replaces CJC/Ipa for more robust GH effect)
- DSIP 200-300 mcg SC 30-45 minutes before bed
Morning Peptide Stack (Separate From Sleep Stack)
- Semax 300-600 mcg intranasal for morning alertness/cognition
- OR Selank 300 mcg intranasal for morning calm alertness
- Rationale: These support daytime function; don't use evening as they may be mildly stimulating
Circadian Rhythm Protocol Layer
- Fixed sleep/wake times within 30-minute window, including weekends
- Morning bright light within 30 minutes of waking (outdoor preferred)
- Daylight exposure targeted throughout day (10,000+ lux cumulative)
- Amber/blue-blocker glasses 1-2 hours before bed
- Epitalon cycle: 5-10 mg SC daily for 10-20 days each quarter
- Rationale: Epitalon may support pineal function and circadian rhythm restoration in aging users
HPA Axis Support
- Ashwagandha (KSM-66) 600 mg split morning/evening
- Phosphatidylserine 300 mg evening if cortisol issues
- Rhodiola rosea 300-400 mg morning (avoid evening; mildly stimulating)
- Regular meditation or breathwork practice
Blood Glucose / Insulin Stability (Sleep Disruptor)
- Metformin 500 mg evening if glucose dysregulation present
- Consider CGM monitoring to identify nighttime glucose drops or spikes
- Protein-containing snack 1-2 hours before bed if overnight hypoglycemia pattern
Advanced Delivery Strategies
Dual-route DSIP:
- Some users report enhanced effect from combining delivery routes
- E.g., intranasal DSIP 200 mcg at 9 PM + subcutaneous DSIP 100 mcg at 11 PM before bed
- Rationale: Two exposure peaks spanning the sleep period
- Practical issue: More preparation and injection burden
Pulsatile Dosing:
- Some advanced users take DSIP 3-4 times during the day at lower doses (50-100 mcg each) in addition to evening dose
- Rationale: Theoretical mimicking of endogenous release pattern
- Evidence: Weak; mostly experimental
- Risk: More frequent injections without clear incremental benefit
Complex Stack Examples
The "Full Peptide Sleep Protocol":
- Morning: Semax 600 mcg intranasal, fasted workout, bright light
- Afternoon: Second Semax dose 300 mcg, lunch with protein
- Evening: Foundation stack (magnesium, glycine, L-theanine, apigenin, 0.3 mg melatonin)
- Bedtime: DSIP 250 mcg + CJC/Ipa 100/200 mcg SC
The "Stress-Dominant Sleep Disorder Stack":
- Morning: Selank 300 mcg intranasal, Ashwagandha AM dose
- Afternoon: Selank second dose if stressful day
- Evening: Heavier foundation (add phosphatidylserine, increased magnesium)
- Bedtime: DSIP 200-300 mcg SC, consider low-dose progesterone cream (if female or low-T male)
The "Recovery-Focused Stack" (athlete context):
- Workout timing: morning/midday
- Post-workout: BPC-157, TB-500 for tissue recovery
- Evening: Foundation + DSIP + CJC/Ipa for GH-mediated recovery
- Nutrition: Adequate carbs at dinner to blunt cortisol
- Hydration: Adequate before bed without excessive
The "Middle-Aged Male Sleep + Body Composition Stack":
- Enclomiphene 12.5 mg morning for T optimization
- Tesamorelin 1 mg evening for GH/IGF-1/visceral fat
- DSIP 250 mcg bedtime for sleep architecture
- Foundation sleep stack
- Metformin 500 mg evening for metabolic health
Troubleshooting Complex Scenarios
Sleep fragmentation despite adequate total sleep:
- Look for alcohol use (major disruptor of second-half sleep)
- Check for undiagnosed apnea (sleep study even if no obvious symptoms)
- Consider nocturnal GH deficiency (morning IGF-1 may inform)
- Evaluate iron status (ferritin < 50 can cause restless sleep)
Vivid dreams to disturbing degree:
- Reduce or eliminate melatonin
- Reduce DSIP by 50 mcg
- Examine dream content for PTSD elements (consider prazosin consultation)
- Review trazodone, SSRIs if prescribed (often cause dream disturbances)
Early morning awakening (3-4 AM):
- Often signals cortisol rise or sleep maintenance insomnia
- Phosphatidylserine 300 mg at bed may help
- Evaluate for major depression (classic early morning awakening symptom)
- Consider ashwagandha evening dose
Racing thoughts at bedtime:
- Doesn't mean "more DSIP"
- Breathwork, journaling, meditation practice
- Selank for daytime anxiolysis reducing evening buildup
- Address source stressors systematically
Lab Monitoring for Advanced Users
At this level of stack complexity, periodic labs are reasonable:
- Comprehensive metabolic panel, CBC quarterly
- HbA1c, fasting glucose, insulin, cortisol AM quarterly
- IGF-1 (if on GH-axis peptides) quarterly
- Testosterone, estradiol, LH/FSH, SHBG (if on HPG peptides) quarterly
- Vitamin D, ferritin, B12, magnesium semi-annually
- Lipid panel semi-annually
- TSH, free T4, free T3 annually
Exit Strategy
Advanced protocols should include a stepped exit plan if simplification is desired:
- Month 1: Remove evening GH peptides, observe effect on sleep
- Month 2: Remove DSIP, reassess sleep quality
- Month 3: Remove melatonin, add back if needed
- Month 4+: Foundation stack only (magnesium, glycine, L-theanine, apigenin)
- Ultimate goal: excellent sleep on foundation stack + sleep hygiene, with peptides available as tools rather than requirements
Cost and Complexity Considerations
Advanced DSIP-inclusive stacks have meaningful financial and time costs:
- $200-500+/month in peptides and supplements
- 15-20 minutes nightly for injection prep, foundation supplement timing
- Ongoing tracking and lab work
- Risk/reward calculation for non-severe sleep issues favors simpler approaches
The "Is This Worth It?" Question
Advanced protocols are worth implementing when:
- Sleep is genuinely problematic and affecting function
- Simpler interventions have been tried and insufficient
- Resources (money, time, tracking capacity) are available
- Approach aligns with broader health optimization goals
Advanced protocols are NOT worth implementing when:
- Basic sleep hygiene has not been tried or is not consistent
- Expectation is dramatic transformation (not realistic)
- Resources are limited (simpler approaches are more sustainable)
- Sleep issues are symptoms of untreated conditions (anxiety, depression, apnea)
Commonly Stacked With
Thoughtful Stack Construction for Sleep
Because DSIP's sleep effects are modest, most users combine it with other evidence-based sleep supports rather than relying on DSIP alone. Common and rational stacks include:
The "Clean Sleep Stack"
Foundation stack for non-severe sleep issues, minimal pharmacological load:
- DSIP 200 mcg SC 30-60 minutes before bed
- Magnesium glycinate 300-400 mg 1-2 hours before bed
- L-theanine 200 mg 30-60 minutes before bed
- Glycine 3-5 g at bedtime
- Apigenin 50 mg (from chamomile extract) 30 minutes before bed
- Sleep hygiene foundations (dark room, cool temperature, no screens 1 hour before bed, consistent timing)
The "Deeper Sleep Stack"
For users pursuing maximum slow-wave sleep enhancement:
- DSIP 250-300 mcg SC 60 minutes before bed
- Low-dose melatonin 0.3-0.5 mg (NOT 3-10 mg) 30 minutes before bed
- Glycine 5 g at bedtime
- Magnesium glycinate 400 mg 1-2 hours before bed
- Ashwagandha 300 mg (KSM-66 extract) evening
- Sleep hygiene basics
DSIP + Epitalon
Some peptide practitioners pair DSIP with Epitalon as a "circadian restoration" stack:
- DSIP 200 mcg SC 30-60 minutes before bed
- Epitalon 5-10 mg SC daily or cycle 10-20 days per quarter
- Rationale: DSIP for acute sleep promotion; Epitalon for circadian rhythm restoration via pineal effects
- Evidence for this combination is anecdotal; both compounds have thin evidence bases
DSIP for Stress/Anxiety
When using DSIP primarily for stress-modulating effects rather than sleep:
- DSIP 100-200 mcg SC evening OR afternoon (lower doses, earlier timing)
- Consider pairing with Selank 300 mcg intranasal 1-2x daily for daytime anxiolysis
- Or Semax 300-600 mcg intranasal for cognitive-anxiolytic balance
- Ashwagandha 300-600 mg daily for adaptogen support
- Regular exercise and stress management foundations
DSIP + GH-Axis Peptides
For evening GH peptide users (pragmatic stack alignment):
- CJC-1295 + Ipamorelin 100/200 mcg SC at bedtime (or 90 min before)
- DSIP 200 mcg SC 30 minutes before bed
- Mechanism: CJC/Ipamorelin enhances GH pulse during deep sleep; DSIP may enhance sleep depth. Theoretically synergistic.
- Monitor: Morning grogginess could be additive; start conservatively.
PCT / TRT Sleep Support
Men on hormonal therapy who struggle with sleep during transitions:
- DSIP 200 mcg SC evening
- Magnesium glycinate 400 mg evening
- 5-HTP 100-200 mg evening (caution if on SSRIs)
- Address underlying hormone issues (appropriate E2 management, dose timing, etc.)
Alcohol Withdrawal Adjunct (Physician-Supervised Only)
For medically-supervised alcohol detoxification where DSIP has some historical evidence:
- DSIP 200-300 mcg SC at bedtime
- Alongside standard medical management (benzodiazepines titrated, thiamine, electrolyte correction, etc.)
- NOT a substitute for standard withdrawal management
- Should only be used under medical supervision in this context
Combinations to Approach with Caution
- Benzodiazepines: Potential additive sedation; generally avoid or use reduced BZD dose if combining
- Z-drugs (zolpidem, eszopiclone): Additive sedation possible; consider reduced Z-drug dose if combining; DSIP may make it easier to taper off chronic Z-drug use
- Opioids: DSIP's mild opioid-potentiating effects are theoretical; caution in opioid users; no strong reported interactions
- Alcohol: Increased sedation; avoid combining or use minimal alcohol
- Antihistamines (diphenhydramine, doxylamine): Additive sedation; often unnecessary stacking
- High-dose melatonin (>3 mg): Excessive sleep pressure may produce vivid dreams, hangover; low-dose melatonin is preferred
- CBD or cannabis: Additive effects on sleep; both can help sleep but together may oversedate
Pharmacological Logic of Stacking
The ideal DSIP stack approaches sleep through multiple non-overlapping mechanisms:
- DSIP: mild, uncharacterized mechanism, possibly GABAergic/stress modulatory
- Magnesium: NMDA antagonism, muscle relaxation
- Glycine: glycine receptor activity, core body temperature drop
- L-theanine: GABAergic, alpha-wave promotion
- Apigenin: benzodiazepine receptor partial agonist
- Low-dose melatonin: circadian rhythm support (NOT a sedative at physiological doses)
- Ashwagandha: adaptogen, stress response modulation
Combining these at appropriate (modest) doses produces additive effects without overwhelming any single system, and without the dependence/tolerance pattern of pharmaceutical hypnotics.
When DSIP is NOT the Right Choice
- Severe sleep apnea: Address the apnea; no sleep aid fixes this.
- Shift work disorder: DSIP doesn't address the circadian component; light therapy and melatonin timing protocols are better.
- Insomnia secondary to untreated depression or anxiety: Treat the underlying condition.
- Sleep onset issues in children/adolescents: Behavioral interventions first; medical sleep medicine consultation.
- Nightmares or night terrors: Different pharmacology (prazosin for PTSD nightmares, etc.).
- Drug or alcohol withdrawal without medical supervision: Requires proper medical management.
Stack Monitoring
Unlike cardiovascular-risk drugs, DSIP stack monitoring is primarily subjective:
- Sleep quality (use a consumer device: Oura, Whoop, Apple Watch, or detailed sleep diary)
- Morning alertness/grogginess
- Daytime energy and mood
- Stress perception
- Any side effects
Objective measures (lab work) are not typically needed for DSIP itself. General wellness labs as part of broader health maintenance are reasonable.
Related Guides — Nasal Spray Deep Dives — DSIP is one of the few sleep-targeted peptides with intranasal research. For a full tiered review (DSIP is Tier B — moderate evidence), see the 2026 Best Peptide Nasal Sprays guide. For DIY reconstitution steps, see How to Make a Peptide Nasal Spray at Home. For the full reconstitution reference including DSIP ratios, see the Complete Peptide Reconstitution Guide.
Side Effects & Safety
Contraindications
## Absolute Contraindications DSIP must NOT be used in the following circumstances: - **Known allergy or hypersensitivity to DSIP or components** — rare but possible with any peptide - **Pregnancy** — insufficient safety data; peptide modulation of sleep/stress axes not evaluated in pregnancy - **Lactation** — insufficient safety data - **Severe underlying respiratory disease with hypercapnia** — any sleep-affecting intervention requires caution; untreated or poorly-controlled sleep apnea is a specific concern (see below) - **Acute intoxication with sedative substances** — combining DSIP with acute alcohol, benzodiazepine, opioid overdose is additive CNS depression - **Untreated moderate-severe obstructive sleep apnea** — DSIP does not cause apnea but deeper sleep may exacerbate it; treat the apnea (CPAP, oral appliance, surgery) first ## Relative Contraindications / Caution Warranted - **Pediatric and adolescent use**: No safety data; peptide modulation of developing neurology unknown; not recommended - **Elderly with cognitive impairment**: Baseline cognitive evaluation; start with lowest doses; monitor for confusion or gait changes - **History of complex sleep behaviors**: Rare with DSIP but any sleep-affecting compound warrants attention - **Severe depression**: Treat underlying depression; DSIP is not an antidepressant - **Active substance use disorder**: Overall addiction-neutral but behavioral patterns around sleep aids merit attention - **Unstable mental health conditions**: Psychiatric evaluation before starting any sleep-affecting compound - **Severe renal or hepatic impairment**: Peptide clearance may be altered; limited data - **Active seizure disorder**: No clear interaction but any CNS-affecting compound requires caution; discuss with neurologist - **Concurrent heavy alcohol use**: Additive sedation possible; alcohol itself disrupts sleep architecture - **Occupational safety considerations**: Next-day alertness should be verified before operating vehicles or equipment ## Specific Drug Interactions Limited formal interaction studies exist for DSIP. The following concerns are extrapolated from pharmacology: - **Benzodiazepines** (alprazolam, lorazepam, diazepam, etc.): Additive CNS depression possible; reduce BZD dose if combining; ideally avoid routine combination - **Z-drugs** (zolpidem, eszopiclone, zaleplon): Similar concerns; consider one or the other, not both - **Opioids** (morphine, oxycodone, hydrocodone, etc.): Theoretical potentiation via endogenous opioid modulation; caution in opioid-treated patients - **Sedating antidepressants** (trazodone, mirtazapine, doxepin): Additive sedation possible; usually manageable - **Sedating antihistamines** (diphenhydramine, doxylamine): Often redundant; pick one or the other - **Alcohol**: Additive CNS depression; avoid combining - **Muscle relaxants** (cyclobenzaprine, carisoprodol): Additive sedation - **Gabapentin/pregabalin**: Generally no concerning interaction; often used together - **SSRIs/SNRIs**: No clear concern; DSIP may be modestly helpful alongside SSRIs for SSRI-induced insomnia - **Lithium**: No known interaction; caution as always - **Melatonin**: Often combined; low-dose melatonin preferred - **Magnesium**: Synergistic and safe combination - **Stimulants** (caffeine, amphetamines, modafinil): Opposing effects; timing separation more important than absolute avoidance - **Blood pressure medications**: No significant interaction; DSIP may have mild hypotensive effects ## Interactions with Other Research Peptides - **[CJC-1295](/compound/cjc-1295), [Ipamorelin](/compound/ipamorelin), [Tesamorelin](/compound/tesamorelin)**: Often combined in evening stack; generally safe and potentially synergistic - **[Selank](/compound/selank)**: No concerning interaction; sometimes stacked for stress/sleep axis - **[Semax](/compound/semax)**: Semax is stimulating; time-separate from DSIP (Semax morning, DSIP evening) - **[Epitalon](/compound/epithalon)**: Often combined for circadian/pineal support - **[BPC-157](/compound/bpc-157), [TB-500](/compound/tb-500)**: No concerning interaction; different mechanisms ## Pre-Use Considerations Before starting DSIP, consider: 1. **Is sleep hygiene optimized?** No peptide replaces good sleep hygiene. If your bedroom has TV, phone usage continues to bedtime, or schedule is irregular, fix those first. 2. **Have underlying conditions been evaluated?** Sleep apnea, restless legs, untreated depression/anxiety, thyroid dysfunction are all more impactful than DSIP can address. 3. **Have simpler agents been tried?** Magnesium, glycine, L-theanine, apigenin, low-dose melatonin all have better evidence than DSIP and work for many people. 4. **Is this for genuine insomnia or anticipatory use?** People with adequate sleep often don't benefit from sleep aids and may develop psychological dependence. 5. **What's the source?** Gray-market peptide quality varies; investigate supplier. 6. **Is the budget appropriate for the marginal benefit?** DSIP is often not the most cost-effective sleep intervention. ## Monitoring for Adverse Response - Unusual morning sedation persisting past 1-2 hours - Worsening rather than improving sleep - New onset mood changes, depression, or anxiety - Vivid dreams severe enough to disrupt sleep - Any allergic-type reaction (hives, swelling, breathing difficulty) - Injection site reactions beyond mild redness Any of these warrants reduction, discontinuation, or medical evaluation. ## Pregnancy, Lactation, Fertility No human data. Peptide neuromodulators theoretically could affect developing neurology. Avoid during conception efforts, pregnancy, and lactation. ## Pediatric Use Not indicated. Pediatric sleep disorders require specialist evaluation and age-appropriate interventions. ## Driving and Machinery Assess your individual next-day alertness before driving or operating machinery after DSIP use. Most users feel normal by morning, but this is individual. Start with days when you don't have safety-critical activities the next day. ## Competitive Athletics DSIP is not on the World Anti-Doping Agency (WADA) prohibited list as of current reference, but regulations change. Any competitive athlete should verify current status with their sport's governing body. Research peptides in general are under increasing scrutiny. ## Long-Term Use Philosophy While DSIP appears safe long-term based on limited data, the spirit of good pharmacology is to use the minimum for the shortest duration that achieves the goal. Indefinite nightly DSIP use, even if apparently safe, reflects a suboptimal situation — either underlying sleep issues haven't been addressed, or psychological dependence on a sleep aid has developed. Intermittent use and periodic breaks are wise.
Additional Notes
Standard Dose Range
DSIP is dosed in micrograms (mcg) — a detail that matters because many users confuse mg and mcg, leading to dramatic overdosing. All doses below are in micrograms.
| Use Case | Typical Dose | Frequency | Duration |
|---|---|---|---|
| First-time user | 100 mcg | 30-60 min before bed | 1-2 weeks |
| Standard sleep support | 200 mcg | Nightly or 5x/week | Ongoing intermittent |
| Stronger effect seeking | 250-300 mcg | Nightly | Ongoing with breaks |
| Stress/anxiety evening | 100-200 mcg | Evening, earlier | As needed |
| Chronic pain adjunct | 200-300 mcg | Daily | Physician-supervised |
| Alcohol/opioid withdrawal | 200-300 mcg | 2-3x daily | Acute; medical supervision |
Dose Titration Strategy
Standard titration for sleep support:
- Night 1-7: 100 mcg SC 30-60 minutes before bed
- Night 8-14: 150 mcg SC (if Week 1 tolerated well but response minimal)
- Night 15+: 200 mcg SC (target maintenance dose for most users)
- Only if insufficient response: 250 mcg, maximum 300 mcg
- Do NOT exceed 300 mcg: No evidence for superior efficacy; more side effects
Timing Considerations
- 30-60 minutes before intended sleep: Most common recommendation
- 60-90 minutes before bed: Some users prefer; allows peptide to distribute
- Avoid dosing too close to bed: Injection discomfort may delay sleep onset
- Avoid dosing too early: Effect window may pass before intended sleep
Consistency
- DSIP appears most effective with consistent nightly timing
- Irregular dosing may produce variable response
- Sleep schedule consistency matters more than absolute timing
Reconstitution Basics
(See dedicated reconstitution_notes section for detail)
Typical commercial vial: 5 mg DSIP (5,000 mcg) Typical reconstitution: 2 mL bacteriostatic water → 2,500 mcg/mL concentration Typical dose volume on insulin syringe:
- 100 mcg = 0.04 mL = 4 units
- 200 mcg = 0.08 mL = 8 units
- 300 mcg = 0.12 mL = 12 units
Intranasal Dosing
Intranasal DSIP concentrations vary widely by supplier. Typical:
- 5 mg DSIP in 5 mL nasal spray vehicle = 1 mg/mL = 100 mcg per typical spray
- 2 sprays (1 per nostril) = 200 mcg
- Verify product specifications before dosing
Special Populations
Elderly (>65): Start at 100 mcg, monitor for next-day grogginess more carefully. May need lower maintenance dose.
Users with sensitivity to medications: Start at 50 mcg if available; many peptide users are dose-sensitive.
Users with high stress vs. low stress: Higher stress may need slightly higher dose; low-stress users may respond to 100-150 mcg.
Users with chronic pain: Higher doses (250-300 mcg) may be used 2-3x daily under supervision; not recommended for self-directed use.
Athletes in heavy training: Standard doses; recovery demands don't require higher dosing.
Missed Dose Management
- If more than 2 hours after intended sleep time: skip dose, resume next night
- DSIP is not a chronic maintenance drug that requires continuity — single missed doses have no consequence
- Do NOT take during daytime to compensate for missed night dose
Discontinuation
- No taper required; stop abruptly
- No withdrawal syndrome
- No rebound insomnia
- Can be resumed at any time at previous effective dose
Cost and Access Considerations
- Research chemical peptide sources (primary availability)
- Typical costs: $30-80 per 5 mg vial (50-100 doses at 100 mcg)
- Quality varies dramatically — use reputable suppliers with batch testing
- Nasal sprays often more expensive per dose than injection
- Not covered by any insurance (not FDA-approved)
- Not available through conventional pharmacies
Quality Considerations
Because DSIP is sold exclusively through research chemical channels, quality variability is substantial:
- Reputable research chemical suppliers: Third-party tested, published COAs, consistent batches. Best option.
- Major peptide-focused suppliers: Generally reliable; compare batch testing.
- Small/unknown suppliers: High variability; caveat emptor.
- Counterfeit product: Exists in the market; may contain no DSIP or different peptides.
Signs of quality product:
- Sealed vial with intact stopper
- Appropriate labeling (batch number, date, supplier)
- Available COA (certificate of analysis)
- Proper storage history (cold-chain for raw peptide)
- Consistent appearance and reconstitution behavior
Signs of concerning product:
- Unusual color or odor
- Precipitation or cloudiness after reconstitution
- Variable effects between batches
- No COA or verification available
- Price significantly below market
Where to Buy DSIP (Delta Sleep-Inducing Peptide)
Compare 10 listings across 7 vendors — from $29.00
Frequently Asked Questions
What is the recommended DSIP (Delta Sleep-Inducing Peptide) dosage?
The typical dose range for DSIP (Delta Sleep-Inducing Peptide) is 100–300 mcg per injection. It is usually administered Once daily, 30–60 minutes before bedtime. Always start with the lowest effective dose.
How often should I take DSIP (Delta Sleep-Inducing Peptide)?
Once daily, 30–60 minutes before bedtime
Does DSIP (Delta Sleep-Inducing Peptide) need to be cycled?
Yes, typical cycle length is 10–14 days; can repeat after 1-week break.
What are DSIP (Delta Sleep-Inducing Peptide) side effects?
## Overall Safety Profile DSIP has one of the cleanest safety profiles of any peptide in the research chemical space. In 40+ years of research and clinical use, no serious adverse events have been reported in controlled trials or large case series. The compound lacks the significant liabilities of benzodiazepines (dependence, withdrawal, cognitive impairment), z-drugs (complex sleep behaviors, hangover, tolerance), or sedating antihistamines (anticholinergic effects, next-day grogginess). This favorable safety profile is one of the main reasons DSIP has retained a user base despite modest efficacy. That said, "no serious adverse events in controlled trials" reflects a relatively small aggregate patient exposure — probably a few hundred patients in all published trials combined. Rare but important adverse events would not necessarily have been detected at that exposure level. The following side effects have been reported in trials and post-marketing use: ## Common Side Effects (5-15% of users) - **Drowsiness or grogginess next morning**: Especially with higher doses or late-night injection. Usually resolves within a few hours of waking. More common in slow metabolizers or those dosing above 300 mcg. - **Vivid dreams**: Some users report unusually vivid or memorable dreams, sometimes including lucid dreaming. Generally neutral or positive but can be disruptive in some users. - **Injection site reactions** (for SC users): Mild redness, slight swelling, or transient discomfort at the injection site. Resolves within hours. Proper injection technique and site rotation minimize. - **Nasal irritation** (for intranasal users): Mild burning, dryness, or congestion from the spray vehicle rather than DSIP itself. Usually short-lived. ## Uncommon Side Effects (1-5%) - **Headache**: Mild, usually self-limiting. More common in first 1-2 uses. - **Dizziness**: Usually mild; rare. - **Nausea**: Uncommon; mostly anecdotal. - **Mood changes**: A minority of users report subtle mood effects, either positive (calm, contentment) or neutral (emotional blunting). True dysphoric reactions are rare. - **Mild fatigue into next day**: Usually resolves with dose reduction. ## Rare Side Effects (<1% or case reports) - **Sleep disruption** (paradoxical): A small subset of users report WORSE sleep with DSIP — restless nights, early awakening, or vivid dreams preventing sleep. Not a common reaction but worth noting. - **Feeling of disinhibition**: Rare reports of mild euphoric or disinhibited feeling, usually at higher doses; not addictive but occasionally pleasant. - **Allergic reactions**: Theoretical risk of injection site reaction or systemic allergic response. Rare but possible with any peptide. ## What Has NOT Been Reported Reassuringly, DSIP has NOT been associated with: - Dependence or withdrawal syndrome - Tolerance to sleep effects (though some report diminished response with very frequent use) - Cognitive impairment or memory effects - Respiratory depression (major advantage over benzodiazepines, opioids) - Cardiovascular effects - Driving impairment - Morning rebound insomnia - Complex sleep behaviors (sleep-eating, sleep-driving — issues with z-drugs) - Paradoxical aggression or behavioral disturbance - Drug interactions of major clinical consequence (though formal interaction studies are limited) - Effects on hormones outside of acute transient changes ## Dose-Dependent Patterns Side effects are generally mild and dose-dependent: - 100 mcg SC: minimal to no side effects in most users - 200 mcg SC: occasional mild next-day grogginess; vivid dreams more common - 300 mcg SC: higher chance of morning grogginess, more vivid dreams - 500+ mcg SC: often produces lingering effects into next day; not typically recommended ## Intranasal vs. Subcutaneous Tolerability Intranasal DSIP generally produces milder side effects than subcutaneous, likely due to: - Lower systemic peptide exposure (less absorbed intranasally) - Absence of injection-site reactions - Possibly different CNS distribution pattern However, intranasal also appears to produce somewhat less sleep benefit in responders compared to SC, reflecting the dose/exposure trade-off. ## Long-Term Use Considerations Long-term safety data is essentially absent. The oldest controlled trials treated subjects for a few weeks. Post-marketing surveillance from research chemical suppliers does not exist in a systematic form. Users who have used DSIP chronically for years generally report no obvious issues, but this is anecdotal. Prudent practice: - Intermittent rather than continuous use - Dose cycles (e.g., 5 nights on, 2 nights off; or every other night) - Periodic breaks (e.g., 2-4 weeks off every 3-6 months) - Focus on underlying sleep hygiene rather than indefinite pharmacological dependence on a sleep aid (even a benign one) ## Special Populations - **Pregnancy/lactation**: No data. Avoid. - **Elderly**: Probably tolerated but may be more prone to next-day effects; start lower doses. - **Hepatic/renal impairment**: Limited data; peptide clearance pathways may be altered. - **Cognitive impairment**: Generally considered safe but monitor carefully; not a first-line sleep aid in dementia. - **Children/adolescents**: No data. Should not be used. - **History of substance use disorder**: DSIP has no known addiction liability, but behavioral patterns around any sleep aid merit attention. ## Adverse Reaction Management If side effects occur: - Minor drowsiness/grogginess: Reduce dose by 50%, dose earlier in evening - Vivid dreams to the point of disruption: Consider dose reduction or drug holiday - Injection site reaction: Rotate sites, use smaller needle (31g insulin syringe), improved technique - Nasal irritation: Check product quality, consider alternate delivery route - Any concerning or unexpected reaction: Discontinue, evaluate with physician - Suspected allergic reaction: Discontinue immediately, seek medical attention
Where can I buy DSIP (Delta Sleep-Inducing Peptide)?
Compare 10 listings from 7 vendors on our price comparison page — starting from $29.00.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.